Search for a trial | Research with human participants

1 results

Interventional, open-label, single- and sequential-ascending-dose study investigating the safety, tolerability and pharmacokinetic profile of Lu AF28996 in healthy young men.

Approved WMORecruitment stopped

Lu AF28996 is an orally administered investigational compound of a potent, long-acting dopamine agonist, Lu AA40326, currently under development by H. Lundbeck A/S for the treatment of Parkinson*s disease (PD). Primary Objective:to investigate the…